2011
DOI: 10.1093/ije/dyq249
|View full text |Cite
|
Sign up to set email alerts
|

Low human papillomavirus prevalence in head and neck cancer: results from two large case–control studies in high-incidence regions

Abstract: A very low prevalence of HPV DNA and serum antibodies was observed among cases in both CE and LA. The proportion of head and neck cancer caused by HPV may vary substantially between different geographical regions and studies that are designed to evaluate the impact of HPV vaccination on HNSCC need to consider this heterogeneity.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

17
147
2
10

Year Published

2012
2012
2022
2022

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 163 publications
(176 citation statements)
references
References 55 publications
17
147
2
10
Order By: Relevance
“…5 Graphic representation for microvessel density/mm2 for tumor stroma (MD/TS) and microvessel density/mm2 for tumor (MD/T) in esophageal adenocarcinoma we studied Chung (2007) supports the same opinion, reporting that p53 can be considered a marker of transformation from Barrett's esophagus into esophageal adenocarcinoma [1]. P53 mutations were associated with low histological tumor differentiation and low survival rate with esophageal adenocarcinoma [7,9,10], these results coming to support the results of our study-intensity marking (+++) of p53 in poorly differentiated esophageal adenocarcinoma.…”
Section: Discussionsupporting
confidence: 61%
“…5 Graphic representation for microvessel density/mm2 for tumor stroma (MD/TS) and microvessel density/mm2 for tumor (MD/T) in esophageal adenocarcinoma we studied Chung (2007) supports the same opinion, reporting that p53 can be considered a marker of transformation from Barrett's esophagus into esophageal adenocarcinoma [1]. P53 mutations were associated with low histological tumor differentiation and low survival rate with esophageal adenocarcinoma [7,9,10], these results coming to support the results of our study-intensity marking (+++) of p53 in poorly differentiated esophageal adenocarcinoma.…”
Section: Discussionsupporting
confidence: 61%
“…In North America, the proportion of HPV-positive OPSCC ranges between 60 and 70%, 6 in Australia it is reported to be 46%, in Asia 25-50%, and in South America 4.4%. [7][8][9] In Western European countries including United Kingdom, France, and Germany, reported proportions vary between 40 and 60%, and The Netherlands appeared to have the lowest proportion of about 20% in 2000-2006, but apparently increasing to 30% in 2010. 8,10,11 Studies in Northern Europe have reported higher proportions, up to 93% in tonsillar carcinomas in Sweden.…”
mentioning
confidence: 99%
“…Despite using the most sensitive method (PCR), we still observed a large variation in HPV detection rates, which can be explained by the relationship between results and sample sizes. In fact, the Kleist et al study observed an 80% positivity among 5 samples, while Ribeiro et al only detected HPV in 3.8% of cases among 78 tumors (Kleist et al, 2000;Ribeiro et al, 2011).…”
Section: Human Papillomavirus and Related Diseases -From Bench To Bedmentioning
confidence: 93%
“…Thus, to obtain the most accurate results for the relationship between HPV and OSCC, future studies should only select biopsied tissues for HPV testing. In addition to the previously mentioned reviews, studies examining HPV infection in OSCC reported a wide range of detection rates from 0 to 61% (Herrero et al, 2003;Koskinen et al, 2003;Mishra et al, 2006;Ribeiro et al, 2011;Smith et al, 2004a). Varying sampling techniques together with widely divergent PCR methods across the studies explain most of this variability.…”
Section: Incidence In Oral Tumorsmentioning
confidence: 98%
See 1 more Smart Citation